Litigation Details for Hy-Vee, Inc. v. Bausch Health Companies Inc. (N.D. Cal. 2020)
✉ Email this page to a colleague
Hy-Vee, Inc. v. Bausch Health Companies Inc. (N.D. Cal. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-02-17 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | William Haskell Alsup |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,780,987; 8,323,692 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Hy-Vee, Inc. v. Bausch Health Companies Inc.
Details for Hy-Vee, Inc. v. Bausch Health Companies Inc. (N.D. Cal. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-02-17 | 1 | Complaint | 1 Patent No. Expiration 6,340,475 (‘475 patent) …Book patent (the ‘692 patent), as well as two non-Orange Book listed 6 patents (the ‘667 patent and …and U.S. Patent No. 8,329,215 (“the ‘215 patent”)). 7 151. The ‘215 patent, like the ‘667 patent… 23 Plaintiff in the patent lawsuit, paid Lupin, the defendant in the patent lawsuit the reverse of … of the listed patents. The manufacturer must list in the Orange Book any such patents that issue 13 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |